Longevity & Bioregulators · Source-reviewed dossier
Pinealon
Source-Reviewed Research Dossier
Pinealon is a short synthetic peptide studied in cellular stress and animal neurodevelopment models. Public evidence is limited and does not establish cognitive enhancement, neuroprotection or anti-aging effects in humans.
Compound overview
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.
Product identity
- Product type
- Peptide research compound
- Catalog family
- Pinealon
- Research category
- Longevity & Bioregulators
- Catalog molecular formula
- C15H26N6O8
- Catalog molecular weight
- 418.40 g/mol
- Catalog sequence
- Glu-Asp-Arg
- Evidence status
- Cell and rodent evidence; no established controlled human outcome evidence
- Intended use
- Research, development and manufacturing use only
Literature reference parameters
- Compound or material class
- Short synthetic peptide bioregulatorCatalog-family identity
- Evidence scope
- Cell and rodent evidence; no established controlled human outcome evidenceDo not generalize beyond the cited model
- Source review
- Primary or authoritative records linked belowChecked 2026-09-01
Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.
How Pinealon is studied
A target-to-pathway view grounded in the linked research records.
Reported research findings
What published studies report about Pinealon
Reported outcomes are paired with their experimental model and evidence boundary.
Cell viability and free-radical processes were measured
A 2011 study evaluated Pinealon in cultured cells under experimental stress conditions.
In-vitro endpoints do not establish a clinical neuroprotective effect.
Read the primary studyPrenatal hyperhomocysteinemia outcomes were preclinical
A 2012 report studied Pinealon in offspring from a rat prenatal hyperhomocysteinemia model.
Developmental findings in rats cannot be generalized to humans.
Read the primary studyCatalog options
Variant specifications
Pack-level catalog data; lot-level controls remain document-specific.
Specification & documents for PIN5
Product specification
Single-component peptide · 5 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Lot documentation
Request by lot: CoA, HPLC purity and MS identity
Specification & documents for PIN10
Product specification
Single-component peptide · 10 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Lot documentation
Request by lot: CoA, HPLC purity and MS identity
Quality documentation
Document availability is stated honestly and can vary by catalog variant or lot.
Analytical interpretation
Interpret the documents, not just the headline number.
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Research context
Published studies and regulatory records, not customer testimonials or usage guidance.
Cell viability and free-radical processes were measured
In-vitro endpoints do not establish a clinical neuroprotective effect.
View primary recordPrenatal hyperhomocysteinemia outcomes were preclinical
Developmental findings in rats cannot be generalized to humans.
View primary recordCurated references
Third-party publications selected for direct relevance.
-
01
Cell study
Pinealon effects on cell viability and proliferative processes
Cell study. 2011. PMID 21978084.
-
02
Rat developmental study
Pinealon in a prenatal hyperhomocysteinemia model
Preclinical study. 2012. PMID 22567179.
Pinealon questions
Concise answers for researchers comparing identity, evidence and catalog variants.
What is Pinealon?
Pinealon is a short synthetic peptide studied in cellular stress and animal neurodevelopment models. Public evidence is limited and does not establish cognitive enhancement, neuroprotection or anti-aging effects in humans.
What evidence is available for Pinealon?
The accessible literature is small and predominantly preclinical.
Does the cited research validate this catalog material?
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
Which quality documents can be requested?
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
How should Pinealon be stored?
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge tools
Continue with structured evidence
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Ready to request a quote?
Selected: PIN10 · 10 mg × 10 vials